LGD-4033, also known by the developmental code name VK5211 and by the black-market name Ligandrol, is a selective androgen receptor modulator which is under development for the treatment of muscle atrophy in people with hip fracture. From Wikipedia
The Swiss athlete claims Ligandrol entered her system through intimate contact, supported by negative hair tests and timeline analysis.
